356 related articles for article (PubMed ID: 3050184)
21. [Antimicrobial activities of cefetamet against clinically isolated strains from community acquired respiratory tract infections. Part III].
Matsumoto Y; Ishihara R; Suzuki Y; Nishinari C; Ishii Y; Nakane Y; Endo H
Jpn J Antibiot; 1999 Jun; 52(6):469-77. PubMed ID: 10481811
[TBL] [Abstract][Full Text] [Related]
22. [Resistance study of community respiratory pathogens isolated in China from 2005 to 2007].
Sun HL; Yang QW; Xu YC; Wang H; Xie XL; Chen MJ; Zhang XZ; Liu Y; Ye HF; Sun ZY; Duan Q; Ni YX; Yu YS; Zhao WS; He L; Wang J; Ji P; Liu PP; Zhang LX
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2983-7. PubMed ID: 20137709
[TBL] [Abstract][Full Text] [Related]
23. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1991)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kondou T; Kobayashi K; Satou K; Matsumiya H; Saito A
Jpn J Antibiot; 1995 Aug; 48(8):965-98. PubMed ID: 7474326
[TBL] [Abstract][Full Text] [Related]
24. [Clinical studies on 9, 3"-diacetylmidecamycin in respiratory tract infections in the field of pediatrics (author's transl)].
Iwai N; Sasaki A; Taneda Y; Mizoguchi F; Nakamura H
Jpn J Antibiot; 1982 Mar; 35(3):739-53. PubMed ID: 6285015
[TBL] [Abstract][Full Text] [Related]
25. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1999)].
Shimada K; Nakano K; Ohno I; Okada S; Hayashi K; Yokouchi H; Arakawa M; Gejyo F; Igarashi K; Ikemoto H; Mori T; Okada M; Ozaki K; Igari J; Aoki N; Oguri T; Kitamura N; Terai T; Suzuki Y; Inoue H; Nakadate T; Karasawa Y; Ito C; Yoshida T; Nakata K; Nakatani T; Inagawa H; Ando M; Suga M; Sato K; Kudo K; Kobayashi N; Tosaka M; Hasegawa M; Kohno S; Tomono K; Miyazaki Y; Kobayashi H; Kawai S; Takayasu S; Hirakata Y; Matsuda J; Mochida C; Ito A; Sumitomo M; Nasu M; Nagai H; Matsushima T; Niki Y; Hiramatsu K; Nakano T
Jpn J Antibiot; 2001 Jul; 54(7):331-64. PubMed ID: 11560054
[TBL] [Abstract][Full Text] [Related]
26. [Bacteriological, pharmacokinetic and clinical studies of a rokitamycin syrup in pediatrics].
Sato H; Narita A; Matsumoto K; Nakazawa S; Suzuki H; Nakanishi Y; Nakazawa S; Chikaoka H; Koido R; Kamigaki M
Jpn J Antibiot; 1988 Jun; 41(6):696-711. PubMed ID: 3221434
[TBL] [Abstract][Full Text] [Related]
27. Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens.
Noviello S; Ianniello F; Leone S; Esposito S
J Antimicrob Chemother; 2003 Nov; 52(5):869-72. PubMed ID: 14519672
[TBL] [Abstract][Full Text] [Related]
28. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2001)].
Shimada K; Oguri T; Igari J; Ikemoto H; Mori T; Kitamura N; Nakano K; Suzuki Y; Yokouchi H; Karasawa Y; Terai T; Yamamoto M; Nakata K; Nakatani T; Inoue H; Nakadate T; Inagawa H; Suwabe A; Obata R; Kudo K; Kobayashi N; Ohno I; Okada S; Hayashi K; Kinoshita T; Konosaki H; Arakawa M; Gejyo F; Kobayashi H; Goto H; Igarashi K; Kawai S; Okada M; Ito A; Sumitomo M; Aoki N; Matsushima T; Niki Y; Suga M; Hirakata Y; Aoki S; Matsuda J; Tosaka M; Nasu M; Nagai H; Kohno S; Tomono K; Miyazaki Y; Hiramatsu K; Nakano T
Jpn J Antibiot; 2003 Oct; 56(5):365-95. PubMed ID: 14692377
[TBL] [Abstract][Full Text] [Related]
29. Sensitivity of Staphylococcus aureus and Streptococcus pyogenes isolated from skin infections in 1992 to antimicrobial agents.
Nishijima S; Namura S; Kawai S; Akamatsu H; Asada Y; Kawabata S
J Dermatol; 1994 Apr; 21(4):233-8. PubMed ID: 8056894
[TBL] [Abstract][Full Text] [Related]
30. Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden.
Kallings I; Bengtsson S; Christensen P; Holm SE; Lind L; Kalin M
Scand J Infect Dis Suppl; 1983; 39():100-5. PubMed ID: 6359377
[TBL] [Abstract][Full Text] [Related]
31. [The antimicrobial activity of fluoroquinolone agents against pathogenic organisms in respiratory tract infections and its clinical effect].
Akiyama M; Takahashi A; Nagatake T; Yamashita H; Yoshida T; Rikitomi N; Ohishi K; Tanaka H; Morito T; Utsunomiya Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Sep; 28(9):1174-81. PubMed ID: 2176251
[TBL] [Abstract][Full Text] [Related]
32. [Activity of telithromycin and other oral antibiotics against respiratory tract pathogens with acquired mechanisms of resistance].
Gómez-Garcés JL; Alós JI; Hernáiz C; Gómez C
Enferm Infecc Microbiol Clin; 2004; 22(6):323-7. PubMed ID: 15228898
[TBL] [Abstract][Full Text] [Related]
33. [In vitro comparative activity of moxifloxacin and other antimicrobials against respiratory pathogens].
Prado V; Giangrieco M; Durán C; Ojeda A; van Flaskamp R
Rev Med Chil; 2000 Dec; 128(12):1319-26. PubMed ID: 11227240
[TBL] [Abstract][Full Text] [Related]
34. [Antimicrobial activities of clindamycin against clinical isolated Streptococcus pneumoniae].
Suzuki Y; Ishihara R; Ishii Y; Nakazawa A; Deguchi K
Jpn J Antibiot; 1997 Nov; 50(11):878-86. PubMed ID: 9651606
[TBL] [Abstract][Full Text] [Related]
35. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2005)].
Goto H; Takeda H; Kawai S; Watanabe S; Okazaki M; Shimada K; Nakano K; Yokouchi H; Mori T; Igari J; Oguri T; Yamamoto M; Kudo K; Kobayashi N; Tanaka T; Yoshimura K; Kawabata M; Nakamori Y; Sumitomo M; Inoue H; Nakadate T; Suwabe A; Ashino Y; Aoki N; Honma Y; Suzuki Y; Karasawa Y; Oka M; Kobashi Y; Kohno S; Hirakata Y; Kondou A; Matsuda J; Nakano M; Oikawa S
Jpn J Antibiot; 2008 Aug; 61(4):209-40. PubMed ID: 19024644
[TBL] [Abstract][Full Text] [Related]
36. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1998)].
Ikemoto H; Arakawa M; Gejyo F; Igarashi K; Mori T; Okada M; Ozaki K; Igari J; Aoki N; Oguri T; Kitamura N; Terai T; Sekine O; Suzuki Y; Inoue H; Nakadate T; Karasawa Y; Ito C; Yoshida T; Nakata K; Nakatani T; Ohno I; Okada S; Inagawa H; Kudo K; Kobayashi N; Ando M; Suga M; Sato K; Kondo T; Tosaka M; Kobayashi H; Kawai S; Takayasu S; Kohno S; Tomono K; Shimada K; Nakano K; Miyazaki Y; Izumikawa K; Yamaguchi T; Mochida C; Yokouchi H; Ito A; Sumitomo M; Nasu M; Nagai H; Yamasaki T; Matsushima T; Nakano T
Jpn J Antibiot; 2000 May; 53(5):261-98. PubMed ID: 10923284
[TBL] [Abstract][Full Text] [Related]
37. Comparative antimicrobial activity of the new macrolide flurithromycin against respiratory pathogens.
Nord CE; Lindmark A; Persson I
Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):71-3. PubMed ID: 3132384
[TBL] [Abstract][Full Text] [Related]
38. [Antimicrobial activities of major oral antibacterial agents against clinically isolated microbial strains from outpatients with respiratory tract infection].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y
Jpn J Antibiot; 1992 Aug; 45(8):980-9. PubMed ID: 1433904
[TBL] [Abstract][Full Text] [Related]
39. [Antimicrobial activities of clarithromycin against recent obtained clinical isolates].
Suzuki Y; Ishii Y; Ishihara R; Nakazawa A; Deguchi K; Matsumoto Y; Nishinari C; Nakane Y; Fukumoto T
Jpn J Antibiot; 1997 Sep; 50(9):776-93. PubMed ID: 9394238
[TBL] [Abstract][Full Text] [Related]
40. [Susceptibility of bacteria isolated from patients with lower respiratory tract infections to antibiotics (1987)].
Ikemoto H; Watanabe K; Kosakai N; Hayashi Y; Oguri T; Kondou T; Saitou A; Matsumiya H; Ueda K; Terai T
Jpn J Antibiot; 1990 Jan; 43(1):147-80. PubMed ID: 2112206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
